Cell Impact Secures Capital: Rights Issue Concludes, Shares Convert
July 25, 2025, 3:38 pm
Cell Impact successfully concludes its significant rights issue, securing SEK 39.2 million. The capital raise, subscribed 62.6%, boosts the company's financial standing. Attention now shifts to BTA conversion. Paid subscribed shares (BTAs) transition to new shares by August 8, 2025. Trading for BTAs ceases July 31. This move underpins Cell Impact's role as a leading global supplier of advanced flow plates for fuel cells and electrolyzers, leveraging its unique Cell Impact Forming™ technology for sustainable energy solutions. The capital positions Cell Impact for expansion and innovation in the green tech sector.
Cell Impact has bolstered its financial foundation. The company recently completed a substantial rights issue. This capital raise aimed to strengthen its balance sheet. It also supports future growth initiatives. The outcome confirms a vital step forward.
The rights issue received strong support. Cell Impact's Board approved it May 20, 2025. Shareholders sanctioned it June 19, 2025. Subscription rates were notable. Total subscriptions reached 62.6 percent. This included 53.6 percent with pre-emptive rights. An additional 9.0 percent subscribed without such rights.
The company successfully raised approximately SEK 39.2 million. This amount is calculated before issue-related costs. Crucially, guarantee commitments were not utilized. This signals robust investor confidence. The subscription price was set at SEK 0.02 per share.
Now, the focus shifts to share conversion. Paid subscribed shares, known as BTAs, are converting. This process marks a significant milestone. Cell Impact's rights issue is fully registered. The registration occurred with the Swedish Companies Registration Office, Bolagsverket. This official step initiates the BTA conversion.
Trading in Cell Impact BTAs will soon cease. The ticker is CI BTA. Its ISIN code is SE0025159528. July 31, 2025, marks the final trading day for these securities. Investors should observe this deadline. The record date with Euroclear Sweden AB is August 4, 2025. After this date, BTAs transform. The newly issued shares are expected to be credited to securities accounts. This credit is anticipated by August 8, 2025. This transition finalizes the capital raise. It provides full clarity for shareholders.
The rights issue significantly impacts Cell Impact’s share capital. The total number of outstanding shares will increase substantially. It rises from 696,271,128 shares. The new count reaches 2,657,847,456 shares. This expansion reflects the capital infusion.
The nominal share capital will not increase directly. An extraordinary general meeting approved a capital reduction. This action maintains a quota value of SEK 0.02 per share. This ensures consistency in share valuation.
Additionally, Cell Impact issued warrants to guarantors. These warrants offer future investment opportunities. Each warrant grants the right to subscribe for one additional share. The exercise price for these warrants is SEK 0.03. This is a slight premium over the rights issue price. Warrants can be exercised between July 24, 2026, and August 7, 2026. Full exercise of these warrants could issue another 273,750,000 new shares. This would bring the total share count to 2,931,597,456. This potential dilution is estimated at 9.3 percent. It factors in the rights issue completion.
Cell Impact AB (publ) stands at the vanguard of clean energy. The company operates globally. It specializes in advanced flow plates. These components are critical for modern fuel cells. They are also vital for electrolyzers. Fuel cells produce electricity efficiently. Electrolyzers generate green hydrogen. Both are cornerstones of a sustainable future.
Cell Impact's innovation is its patented technology. It developed Cell Impact Forming™. This unique high-velocity forming method redefines production. It enables scalable, cost-efficient manufacturing of flow plates. Traditional methods often lag behind. Cell Impact Forming™ boasts superior environmental credentials. It uses no water. Its electricity consumption is minimal. This aligns perfectly with global sustainability targets. The technology underscores Cell Impact's commitment. It provides tangible solutions for a greener world.
This fresh capital injection strengthens Cell Impact's strategic stance. It provides essential resources for corporate expansion. The funds will fuel crucial research and development. They will also support scaling production capacities.
Demand for fuel cells and electrolyzers is surging. Governments globally advocate for decarbonization policies. Industries worldwide seek cleaner energy alternatives. Cell Impact is optimally positioned to leverage this market trend. Its specialized flow plates are indispensable. They enhance efficiency in hydrogen-based systems.
The company's listing on Nasdaq First North Growth Market boosts its profile. It attracts investors focusing on green technology. The successful rights issue validates investor confidence. It reaffirms Cell Impact’s robust business model. It also confirms its technological leadership. Cell Impact aims to accelerate market penetration. It seeks to solidify its position. It intends to be the leader in flow plate manufacturing. The future of sustainable energy hinges on such innovations.
Cell Impact relied on expert advice throughout this complex process. Stockholm Corporate Finance AB served as its financial adviser. Wåhlin Advokater AB provided critical legal counsel. Aqurat Fondkommission AB acted as the issuing agent. These partnerships ensured a streamlined and compliant transaction.
The information released adheres to strict regulatory frameworks. It complies with the EU Market Abuse Regulation. However, specific jurisdictional limitations apply. This release is not an offer. It does not constitute an offer to acquire or subscribe for securities. Its distribution faces restrictions in several countries. These include the United States, Australia, and Japan. Investors in particular regions must adhere to local laws. Cell Impact maintains full transparency. It provides an information document for all interested parties. This document is accessible on its website. Cell Impact remains steadfast in its commitment to regulatory best practices.
This capital raise and share conversion mark a new chapter. Cell Impact stands ready for continued growth. It reinforces its dedication to clean energy solutions. The company builds on its technological advantage. It expands its global footprint. This strategic move secures its vital role. It shapes the evolving energy landscape. Cell Impact moves decisively forward. It drives innovation. It builds a sustainable tomorrow.
Cell Impact's Capital Infusion
Cell Impact has bolstered its financial foundation. The company recently completed a substantial rights issue. This capital raise aimed to strengthen its balance sheet. It also supports future growth initiatives. The outcome confirms a vital step forward.
The rights issue received strong support. Cell Impact's Board approved it May 20, 2025. Shareholders sanctioned it June 19, 2025. Subscription rates were notable. Total subscriptions reached 62.6 percent. This included 53.6 percent with pre-emptive rights. An additional 9.0 percent subscribed without such rights.
The company successfully raised approximately SEK 39.2 million. This amount is calculated before issue-related costs. Crucially, guarantee commitments were not utilized. This signals robust investor confidence. The subscription price was set at SEK 0.02 per share.
Transitioning to New Shares
Now, the focus shifts to share conversion. Paid subscribed shares, known as BTAs, are converting. This process marks a significant milestone. Cell Impact's rights issue is fully registered. The registration occurred with the Swedish Companies Registration Office, Bolagsverket. This official step initiates the BTA conversion.
Trading in Cell Impact BTAs will soon cease. The ticker is CI BTA. Its ISIN code is SE0025159528. July 31, 2025, marks the final trading day for these securities. Investors should observe this deadline. The record date with Euroclear Sweden AB is August 4, 2025. After this date, BTAs transform. The newly issued shares are expected to be credited to securities accounts. This credit is anticipated by August 8, 2025. This transition finalizes the capital raise. It provides full clarity for shareholders.
Share Structure Evolution
The rights issue significantly impacts Cell Impact’s share capital. The total number of outstanding shares will increase substantially. It rises from 696,271,128 shares. The new count reaches 2,657,847,456 shares. This expansion reflects the capital infusion.
The nominal share capital will not increase directly. An extraordinary general meeting approved a capital reduction. This action maintains a quota value of SEK 0.02 per share. This ensures consistency in share valuation.
Additionally, Cell Impact issued warrants to guarantors. These warrants offer future investment opportunities. Each warrant grants the right to subscribe for one additional share. The exercise price for these warrants is SEK 0.03. This is a slight premium over the rights issue price. Warrants can be exercised between July 24, 2026, and August 7, 2026. Full exercise of these warrants could issue another 273,750,000 new shares. This would bring the total share count to 2,931,597,456. This potential dilution is estimated at 9.3 percent. It factors in the rights issue completion.
Innovating in Green Technology
Cell Impact AB (publ) stands at the vanguard of clean energy. The company operates globally. It specializes in advanced flow plates. These components are critical for modern fuel cells. They are also vital for electrolyzers. Fuel cells produce electricity efficiently. Electrolyzers generate green hydrogen. Both are cornerstones of a sustainable future.
Cell Impact's innovation is its patented technology. It developed Cell Impact Forming™. This unique high-velocity forming method redefines production. It enables scalable, cost-efficient manufacturing of flow plates. Traditional methods often lag behind. Cell Impact Forming™ boasts superior environmental credentials. It uses no water. Its electricity consumption is minimal. This aligns perfectly with global sustainability targets. The technology underscores Cell Impact's commitment. It provides tangible solutions for a greener world.
Strategic Positioning and Future Outlook
This fresh capital injection strengthens Cell Impact's strategic stance. It provides essential resources for corporate expansion. The funds will fuel crucial research and development. They will also support scaling production capacities.
Demand for fuel cells and electrolyzers is surging. Governments globally advocate for decarbonization policies. Industries worldwide seek cleaner energy alternatives. Cell Impact is optimally positioned to leverage this market trend. Its specialized flow plates are indispensable. They enhance efficiency in hydrogen-based systems.
The company's listing on Nasdaq First North Growth Market boosts its profile. It attracts investors focusing on green technology. The successful rights issue validates investor confidence. It reaffirms Cell Impact’s robust business model. It also confirms its technological leadership. Cell Impact aims to accelerate market penetration. It seeks to solidify its position. It intends to be the leader in flow plate manufacturing. The future of sustainable energy hinges on such innovations.
Key Partnerships and Regulatory Compliance
Cell Impact relied on expert advice throughout this complex process. Stockholm Corporate Finance AB served as its financial adviser. Wåhlin Advokater AB provided critical legal counsel. Aqurat Fondkommission AB acted as the issuing agent. These partnerships ensured a streamlined and compliant transaction.
The information released adheres to strict regulatory frameworks. It complies with the EU Market Abuse Regulation. However, specific jurisdictional limitations apply. This release is not an offer. It does not constitute an offer to acquire or subscribe for securities. Its distribution faces restrictions in several countries. These include the United States, Australia, and Japan. Investors in particular regions must adhere to local laws. Cell Impact maintains full transparency. It provides an information document for all interested parties. This document is accessible on its website. Cell Impact remains steadfast in its commitment to regulatory best practices.
This capital raise and share conversion mark a new chapter. Cell Impact stands ready for continued growth. It reinforces its dedication to clean energy solutions. The company builds on its technological advantage. It expands its global footprint. This strategic move secures its vital role. It shapes the evolving energy landscape. Cell Impact moves decisively forward. It drives innovation. It builds a sustainable tomorrow.